Spinal Cord Hemangioblastomas



Hemangioblastomas are histologically benign but highly vascular tumors of the central nervous system that can be sporadic in nature or in association with von-Hippel-Lindau (VHL) syndrome. This chapter presents a comprehensive review of the clinical presentation, surgical technique, adjuvant therapy, and patient outcomes following treatment of spinal cord hemangioblastomas.


Hemangioblastomas Tumor Intramedullary Diagnosis Surgery Treatment 

Supplementary material

Video 14.1

Cervical spinal hemangioblastoma resection (MPG 573236 kb)

Video 14.2

Thoracic spinal cord hemangioblastoma resection (MPG 891280 kb)


  1. 1.
    Sun HI, Ozduman K, Usseli MI, Ozgen S, Pamir MN. Sporadic spinal hemangioblastomas can be effectively treated by microsurgery alone. World Neurosurg. 2014;82(5):836–47. Scholar
  2. 2.
    Chang SD, Meisel JA, Hancock SL, Martin DP, McManus M, Adler JR Jr. Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery. 1998;43(1):28–34. discussion 34-25CrossRefGoogle Scholar
  3. 3.
    Joaquim AF, Ghizoni E, dos Santos MJ, Valadares MG, da Silva FS, Tedeschi H. Intramedullary hemangioblastomas: surgical results in 16 patients. Neurosurg Focus. 2015;39(2):E18. Scholar
  4. 4.
    Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P. Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg. 1989;70(1):24–30. Scholar
  5. 5.
    Murota T, Symon L. Surgical management of hemangioblastoma of the spinal cord: a report of 18 cases. Neurosurgery. 1989;25(5):699–707. discussion 708CrossRefGoogle Scholar
  6. 6.
    Arnautovic K, Arnautovic A (2009) Extramedullary intradural spinal tumors: a review of modern diagnostic and treatment options and a report of a series. Bosnian journal of basic medical sciences/Udruzenje basicnih mediciniskih znanosti = Association of Basic Medical Sciences 9 Suppl 1:40-45.Google Scholar
  7. 7.
    Arnautovic KI, Kovacevic M. CSF-related complications after Intradural spinal tumor surgery: utility of an autologous fat graft. Med Arch. 2016;70(6):460–5. Scholar
  8. 8.
    Garces-Ambrossi GL, McGirt MJ, Mehta VA, Sciubba DM, Witham TF, Bydon A, Wolinksy JP, Jallo GI, Gokaslan ZL. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases. J Neurosurg Spine. 2009;11(5):591–9. Scholar
  9. 9.
    Liu A, Jain A, Sankey EW, Jallo GI, Bettegowda C. Sporadic intramedullary hemangioblastoma of the spine: a single institutional review of 21 cases. Neurol Res. 2016;38(3):205–9. Scholar
  10. 10.
    Mehta GU, Asthagiri AR, Bakhtian KD, Auh S, Oldfield EH, Lonser RR. Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease. J Neurosurg Spine. 2010;12(3):233–42. Scholar
  11. 11.
    Mandigo CE, Ogden AT, Angevine PD, McCormick PC. Operative management of spinal hemangioblastoma. Neurosurgery. 2009;65(6):1166–77. Scholar
  12. 12.
    Kanno H, Yamamoto I, Nishikawa R, Matsutani M, Wakabayashi T, Yoshida J, Shitara N, Yamasaki I, Shuin T, Clinical VHLRGiJ (2009) Spinal cord hemangioblastomas in von Hippel-Lindau disease. Spinal Cord 47 (6):447–452.
  13. 13.
    Roonprapunt C, Silvera VM, Setton A, Freed D, Epstein FJ, Jallo GI. Surgical management of isolated hemangioblastomas of the spinal cord. Neurosurgery. 2001;49(2):321–7. discussion 327-328PubMedGoogle Scholar
  14. 14.
    Takai K, Taniguchi M, Takahashi H, Usui M, Saito N. Comparative analysis of spinal hemangioblastomas in sporadic disease and Von Hippel-Lindau syndrome. Neurol Med Chir. 2010;50(7):560–7.CrossRefGoogle Scholar
  15. 15.
    Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH. von Hippel-Lindau disease. Lancet. 2003;361(9374):2059–67. Scholar
  16. 16.
    Lonser RR, Wait SD, Butman JA, Vortmeyer AO, Walther MM, Governale LS, Oldfield EH. Surgical management of lumbosacral nerve root hemangioblastomas in von Hippel-Lindau syndrome. J Neurosurg. 2003;99(1 Suppl):64–9.PubMedGoogle Scholar
  17. 17.
    Lonser RR, Weil RJ, Wanebo JE, Devroom HL, Oldfield EH. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98(1):106–16. Scholar
  18. 18.
    Van Velthoven V, Reinacher PC, Klisch J, Neumann HP, Glasker S. Treatment of intramedullary hemangioblastomas, with special attention to von Hippel-Lindau disease. Neurosurgery. 2003;53(6):1306–13. discussion 1313-1304CrossRefGoogle Scholar
  19. 19.
    Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfield EH, Zhuang Z. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol. 1997;28(5):540–3.CrossRefGoogle Scholar
  20. 20.
    Shultze F. Further contribution to diagnosis and surgical treatment of tumors of the spinal cord and the spinal cord. Deusch Med. 1912;38:1676–9.Google Scholar
  21. 21.
    Wang C, Zhang J, Liu A, Sun B. Surgical management of medullary hemangioblastoma. Report of 47 cases. Surg Neurol. 2001;56(4):218–26. discussion 226-217CrossRefGoogle Scholar
  22. 22.
    Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest. 1993;91(1):153–9. Scholar
  23. 23.
    Lonser RR, Oldfield EH. Microsurgical resection of spinal cord hemangioblastomas. Neurosurgery. 2005;57(4 Suppl):372–6. discussion 372-376PubMedGoogle Scholar
  24. 24.
    Miller DJ, McCutcheon IE. Hemangioblastomas and other uncommon intramedullary tumors. J Neuro-Oncol. 2000;47(3):253–70.CrossRefGoogle Scholar
  25. 25.
    Butman JA, Linehan WM, Lonser RR. Neurologic manifestations of von Hippel-Lindau disease. JAMA. 2008;300(11):1334–42. Scholar
  26. 26.
    Catapano D, Muscarella LA, Guarnieri V, Zelante L, D'Angelo VA, D'Agruma L. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management. Neurosurgery. 2005;56(6):1215–21. discussion 1221CrossRefGoogle Scholar
  27. 27.
    Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260(5112):1317–20.CrossRefGoogle Scholar
  28. 28.
    Krieg M, Marti HH, Plate KH. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood. 1998;92(9):3388–93.CrossRefGoogle Scholar
  29. 29.
    Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001;48(1):55–62. discussion 62-53PubMedGoogle Scholar
  30. 30.
    Das JM, Kesavapisharady K, Sadasivam S, Nair SN. Microsurgical treatment of sporadic and von Hippel-Lindau disease associated spinal Hemangioblastomas: a single-institution experience. Asian Spine J. 2017;11(4):548–55. Scholar
  31. 31.
    Park CH, Lee CH, Hyun SJ, Jahng TA, Kim HJ, Kim KJ. Surgical outcome of spinal cord hemangioblastomas. J Korean Neurosurg Soc. 2012;52(3):221–7. Scholar
  32. 32.
    Yang S, Yang X, Hong G. Surgical treatment of one hundred seventy-four intramedullary spinal cord tumors. Spine. 2009;34(24):2705–10. Scholar
  33. 33.
    Na JH, Kim HS, Eoh W, Kim JH, Kim JS, Kim ES. Spinal cord hemangioblastoma : diagnosis and clinical outcome after surgical treatment. J Korean Neurosurg Soc. 2007;42(6):436–40. Scholar
  34. 34.
    Oppenlander ME, Spetzler RF. Advances in spinal hemangioblastoma surgery. World Neurosurg. 2010;74(1):116–7. Scholar
  35. 35.
    Pluta RM, Iuliano B, DeVroom HL, Nguyen T, Oldfield EH. Comparison of anterior and posterior surgical approaches in the treatment of ventral spinal hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98(1):117–24. Scholar
  36. 36.
    Hsu W, Bettegowda C, Jallo GI. Intramedullary spinal cord tumor surgery: can we do it without intraoperative neurophysiological monitoring? Child's Nerv Syst. 2010;26(2):241–5. Scholar
  37. 37.
    Clark AJ, Lu DC, Richardson RM, Tihan T, Parsa AT, Chou D, Barbaro NM, Kunwar S, Weinstein PR, Lawton MT, Berger MS, McDermott MW. Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg. 2010;74(1):200–5. Scholar
  38. 38.
    Cushing HBP (1928) Tumors arising from the blood vessels of the brain: Angiomatous malformations and Hemangioblastomas. Springfield,Google Scholar
  39. 39.
    Delisle MF, Valimohamed F, Money D, Douglas MJ. Central nervous system complications of von Hippel-Lindau disease and pregnancy; perinatal considerations: case report and literature review. J Matern Fetal Med. 2000;9(4):242–7.<242::AID-MFM11>3.0.CO;2-5.CrossRefPubMedGoogle Scholar
  40. 40.
    Kurne A, Bakar B, Arsava EM, Tan E. Pregnancy associated quadriparesis in a patient with Von-Hippel Lindau disease. J Neurol. 2003;250(2):234–5.CrossRefGoogle Scholar
  41. 41.
    Ogasawara KK, Ogasawara EM, Hirata G. Pregnancy complicated by von Hippel-Lindau disease. Obstet Gynecol. 1995;85(5 Pt 2):829–31.CrossRefGoogle Scholar
  42. 42.
    Ortega-Martinez M, Cabezudo JM, Fernandez-Portales I, Pineda-Palomo M, Rodriguez-Sanchez JA, Bernal-Garcia LM. Multiple filum terminale hemangioblastomas symptomatic during pregnancy. Case report Journal of neurosurgery Spine. 2007;7(2):254–8. Scholar
  43. 43.
    Omar AI. Bevacizumab for the treatment of surgically unresectable cervical cord hemangioblastoma: a case report. J Med Case Rep. 2012;6:238. Scholar
  44. 44.
    Capitanio JF, Mazza E, Motta M, Mortini P, Reni M. Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system. Crit Rev Oncol Hematol. 2013;86(1):69–84. Scholar
  45. 45.
    Sardi I, Sanzo M, Giordano F, Buccoliero AM, Mussa F, Arico M, Genitori L. Monotherapy with thalidomide for treatment of spinal cord hemangioblastomas in a patient with von Hippel-Lindau disease. Pediatr Blood Cancer. 2009;53(3):464–7. Scholar
  46. 46.
    Patrice SJ, Sneed PK, Flickinger JC, Shrieve DC, Pollock BE, Alexander E 3rd, Larson DA, Kondziolka DS, Gutin PH, Wara WM, McDermott MW, Lunsford LD, Loeffler JS. Radiosurgery for hemangioblastoma: results of a multiinstitutional experience. Int J Radiat Oncol Biol Phys. 1996;35(3):493–9.CrossRefGoogle Scholar
  47. 47.
    Cornelius JF, Saint-Maurice JP, Bresson D, George B, Houdart E. Hemorrhage after particle embolization of hemangioblastomas: comparison of outcomes in spinal and cerebellar lesions. J Neurosurg. 2007;106(6):994–8. Scholar
  48. 48.
    Rodesch G, Gaillard S, Loiseau H, Brotchi J. Embolization of intradural vascular spinal cord tumors : report of five cases and review of the literature. Neuroradiology. 2008;50(2):145–51. Scholar
  49. 49.
    Shin DA, Kim SH, Kim KN, Shin HC, Yoon DH. Surgical management of spinal cord haemangioblastoma. Acta Neurochir. 2008;150(3):215–20.; discussion 220. Scholar
  50. 50.
    Browne TR, Adams RD, Roberson GH. Hemangioblastoma of the spinal cord. Review and report of five cases. Arch Neurol. 1976;33(6):435–41.CrossRefGoogle Scholar
  51. 51.
    Cristante L, Herrmann HD. Surgical management of intramedullary hemangioblastoma of the spinal cord. Acta Neurochir. 1999;141(4):333–9. discussion 339-340CrossRefGoogle Scholar
  52. 52.
    Guidetti B, Fortuna A. Surgical treatment of intramedullary hemangioblastoma of the spinal cord. Report of six cases. J Neurosurg. 1967;27(6):530–40. Scholar
  53. 53.
    Kuharic M, Jankovic D, Splavski B, Boop FA, Arnautovic KI. Hemangioblastomas of the posterior cranial fossa in adults: demographics, clinical, morphologic, pathologic, surgical features, and outcomes. a systematic review. World Neurosurg. 2018;110:e1049–62.CrossRefGoogle Scholar
  54. 54.
    McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J Neurosurg. 1990;72(4):523–32. Scholar
  55. 55.
    Niemela M, Lemeta S, Summanen P, Bohling T, Sainio M, Kere J, Poussa K, Sankila R, Haapasalo H, Kaariainen H, Pukkala E, Jaaskelainen J. Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease. Acta Neurochir. 1999;141(11):1147–56.CrossRefGoogle Scholar
  56. 56.
    Lonser RR, Butman JA, Huntoon K, Asthagiri AR, Wu T, Bakhtian KD, Chew EY, Zhuang Z, Linehan WM, Oldfield EH. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2014;120(5):1055–62. Scholar
  57. 57.
    Pojskić M, Arnautović KI. Microsurgical resection of medulla oblongata hemangioblastoma: 2-dimensional operative video. Oper Neurosurg. 2018;15(5):E64–5.CrossRefGoogle Scholar
  58. 58.
    Pojskić M, Arnautović KI. Microsurgical resection of spinal cord hemangioblastoma: 2-dimensional operative video. Oper Neurosurg. 2018.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of NeurosurgeryUniversity of Tennessee Health Science CenterMemphisUSA
  2. 2.Southmead HospitalBristolUK
  3. 3.Semmes MurpheyMemphisUSA

Personalised recommendations